UBS inks €77m forward-funding deal for UK life sciences asset

UBS Asset Management (UBS-AM) Real Estate & Private Markets (REPM) has agreed to provide £66 mln (€77 mln) in forward funding for a pharmaceutical facility in Stevenage, UK, working with development partner Reef Estates.

Premium subscriber content – please log in to read more or take a free trial.


Latest news

Best read stories